Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Research Funding » OGT Gets $2.6M Grant to Develop Tumor Profiling Assay

OGT Gets $2.6M Grant to Develop Tumor Profiling Assay

Jun 21, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Oxford Gene Technology today announced it has received £1.6 million ($2.6 million) to develop a tumor profiling assay as part of a UK initiative aimed a tumor profiling and data capture.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Even Bigger

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Got Into the Lab Machines

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Not Going to Pay

Science reports that a Dutch research funding agency is combating a ransomware attack.

Science Papers Present Haplotype-Resolved Genomes, MiRNA-Linked Complex Tied to Ribosomal Protein Production

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.

Mar
31
Featured Webinar

Development and Commercialization of a Novel CRISPR-Based SARS CoV-2 Test

Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test. 

What's Popular?

In Clinical Sequencing

  1. Adaptive Biotechnologies Touts New Era of T Cell-Based Dx With T-Detect COVID Launch

    Premium

  2. Adaptive Biotechnologies Q4 Revenues Rise 25 Percent

  3. GenDx HLA Genotyping Products Receives Health Canada IVD Approval

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.